Related Experiment Videos
Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma
A Rydholm1, P Gustafson, B Rööser
1Department of Orthopedics, University Hospital, Lund, Sweden.
Summary
Routine adjuvant radiotherapy is often unnecessary for soft tissue sarcomas of the extremities. Local surgery alone can achieve low recurrence rates for subcutaneous and intramuscular tumors, regardless of grade.
Area of Science:
- Orthopedic Oncology
- Surgical Oncology
- Musculoskeletal Tumors
Background:
- Soft tissue sarcomas of the extremities present a significant challenge in surgical management.
- Treatment decisions often involve balancing limb preservation with oncologic control.
- Adjuvant therapies like radiotherapy are frequently considered to minimize local recurrence.
Purpose of the Study:
- To evaluate the necessity of routine adjuvant radiotherapy in patients with soft tissue sarcomas of the extremities.
- To assess the local recurrence rates associated with limb-sparing surgery alone for specific tumor types.
Main Methods:
- Retrospective analysis of 119 patients with extremity soft tissue sarcomas treated between 1980 and 1986.
- Classification of tumors based on anatomic location: subcutaneous, intramuscular, and extramuscular.
- Focus on local surgery outcomes for subcutaneous and intramuscular tumors, with or without adjuvant radiotherapy.
Main Results:
- A local recurrence rate of less than 10% was observed in 56 patients with subcutaneous and intramuscular tumors treated with wide-margin local surgery without radiotherapy.
- This low recurrence rate was consistent across different malignancy grades.
- The majority of extremity soft tissue sarcomas were found to be subcutaneous or intramuscular.
Conclusions:
- Routine adjuvant radiotherapy is not essential for all patients with soft tissue sarcomas of the extremities.
- Limb-sparing surgery with adequate margins is effective in managing subcutaneous and intramuscular soft tissue sarcomas.
- Local surgery alone can achieve favorable outcomes, with low recurrence rates, for these tumor types.